SYK-623, a δ Opioid Receptor Inverse Agonist, Mitigates Chronic Stress-Induced Behavioral Abnormalities and Disrupted Neurogenesis.

导出 LinkOut

翻译打印收藏纠错

作者： Takashi,Iwai ^[1] ; Rei,Mishima ^[1] ; Shigeto,Hirayama ^[2] ; Honoka,Nakajima ^[1] ; Misa,Oyama ^[1] ; Shun,Watanabe ^[1] ; Hideaki,Fujii ^[2] ; Mitsuo,Tanabe ^[1]

作者单位： Laboratory of Pharmacology, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.;Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan. ^[1] Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.;Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan. ^[2]

关键词 GABA delta opioid depression learning and memory neurogenesis stress

DOI 10.3390/jcm13020608

PMID 38276114

发布时间 2024-10-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical medicine

2024年13卷2期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

SYK-623, a δ Opioid Receptor Inverse Agonist, Mitigates Chronic Stress-Induced Behavioral Abnormalities and Disrupted Neurogenesis.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

SYK-623, a δ Opioid Receptor Inverse Agonist, Mitigates Chronic Stress-Induced Behavioral Abnormalities and Disrupted Neurogenesis.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

检索历史清除